The Patent Finder
BT

Bluerock Therapeutics LP

First filing 2017
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Five patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2035. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Nov 2035
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2020 to 2041.
US 10,745,717 Vectors and Methods for Targeted Integration in Loci Comprising Constitutively Expressed Genes Nov 10, 2035
US 12,394,224 Detecting Cells of Interest in Large Image Datasets Using Artificial Intelligence Feb 20, 2040
US 11,989,960 Detecting Cells of Interest in Large Image Datasets Using Artificial Intelligence Feb 25, 2041
US 11,666,710 Delivery Devices for Therapeutic Substances Apr 13, 2041
US 12,296,154 Delivery Devices for Therapeutic Substances Apr 13, 2041
202420282032203620402041
27 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 6, 2026
    The maintenance fee for Delivery Devices for Therapeutic Substances (US 11,666,710) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 5 of 5

PatentTitleStatusExpiresConfidence
US 10,745,717Vectors and Methods for Targeted Integration in Loci Comprising Constitutively Expressed Genes
In force
 · High confidence
In forceHigh confidence
US 12,394,224Detecting Cells of Interest in Large Image Datasets Using Artificial Intelligence
In force
 · High confidence
In forceHigh confidence
US 11,989,960Detecting Cells of Interest in Large Image Datasets Using Artificial Intelligence
In force
 · High confidence
In forceHigh confidence
US 11,666,710Delivery Devices for Therapeutic Substances
In force
 · High confidence
In forceHigh confidence
US 12,296,154Delivery Devices for Therapeutic Substances
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 5: 27 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited